NOVOCURE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.45 USD | -2.19% |
|
-6.03% | +16.88% |
| 09-03 | NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor | MT |
| 09-03 | Novocure Announces CEO Changes, Effective January 1, 2025 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 19.75 | 24.05 | 23.15 |
| Spread/Res. | -11.65% | -27.44% | -24.62% |
| Spread/Supp. | +5.06% | +47.51% | +8.12% |
| Support | 16.61 | 11.83 | 16.14 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NVCR Stock
- Charts NovoCure Limited
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition